FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3098566790> ?p ?o ?g. }

• W3098566790 endingPage "141" @default.
• W3098566790 startingPage "133" @default.
• W3098566790 abstract "Duchenne muscular dystrophy (DMD) is a severe congenital disease associated with mutation of the dystrophin gene. Supplementation of dystrophin using recombinant adeno-associated virus (rAAV) has promise as a treatment for DMD, although vector-related general toxicities, such as liver injury, neurotoxicity, and germline transmission, have been suggested in association with the systemic delivery of high doses of rAAV. Here, we treated normal or dystrophic dogs with rAAV9 transduction in conjunction with multipotent mesenchymal stromal cell (MSC) injection to investigate the therapeutic effects of an rAAV expressing microdystrophin (μDys) under conditions of immune modulation. Bone-marrow-derived MSCs, rAAV-CMV-μDys, and a rAAV-CAG-luciferase (Luc) were injected into the jugular vein of a young dystrophic dog to induce systemic expression of μDys. One week after the first injection, the dog received a second intravenous injection of MSCs, and on the following day, rAAV was intravenously injected into the same dog. Systemic injection of rAAV9 with MSCs pretreatment improves gene transfer into normal and dystrophic dogs. Dystrophic phenotypes significantly improved in the rAAV-μDys-injected dystrophic dog, suggesting that an improved rAAV-μDys treatment including immune modulation induces successful long-term transgene expression to improve dystrophic phenotypes. Duchenne muscular dystrophy (DMD) is a severe congenital disease associated with mutation of the dystrophin gene. Supplementation of dystrophin using recombinant adeno-associated virus (rAAV) has promise as a treatment for DMD, although vector-related general toxicities, such as liver injury, neurotoxicity, and germline transmission, have been suggested in association with the systemic delivery of high doses of rAAV. Here, we treated normal or dystrophic dogs with rAAV9 transduction in conjunction with multipotent mesenchymal stromal cell (MSC) injection to investigate the therapeutic effects of an rAAV expressing microdystrophin (μDys) under conditions of immune modulation. Bone-marrow-derived MSCs, rAAV-CMV-μDys, and a rAAV-CAG-luciferase (Luc) were injected into the jugular vein of a young dystrophic dog to induce systemic expression of μDys. One week after the first injection, the dog received a second intravenous injection of MSCs, and on the following day, rAAV was intravenously injected into the same dog. Systemic injection of rAAV9 with MSCs pretreatment improves gene transfer into normal and dystrophic dogs. Dystrophic phenotypes significantly improved in the rAAV-μDys-injected dystrophic dog, suggesting that an improved rAAV-μDys treatment including immune modulation induces successful long-term transgene expression to improve dystrophic phenotypes." @default.
• W3098566790 created "2020-11-23" @default.
• W3098566790 creator A5032570492 @default.
• W3098566790 creator A5038008307 @default.
• W3098566790 creator A5060434465 @default.
• W3098566790 creator A5064919780 @default.
• W3098566790 creator A5069152029 @default.
• W3098566790 creator A5074650312 @default.
• W3098566790 creator A5078964807 @default.
• W3098566790 creator A5082934985 @default.
• W3098566790 date "2021-03-01" @default.
• W3098566790 modified "2023-10-15" @default.
• W3098566790 title "Improved transduction of canine X-linked muscular dystrophy with rAAV9-microdystrophin via multipotent MSC pretreatment" @default.
• W3098566790 cites W1600258010 @default.
• W3098566790 cites W1627116606 @default.
• W3098566790 cites W1936484224 @default.
• W3098566790 cites W1963803693 @default.
• W3098566790 cites W1967223729 @default.
• W3098566790 cites W1968543820 @default.
• W3098566790 cites W2000168224 @default.
• W3098566790 cites W2043149070 @default.
• W3098566790 cites W2055111404 @default.
• W3098566790 cites W2055700491 @default.
• W3098566790 cites W2080510653 @default.
• W3098566790 cites W2086344503 @default.
• W3098566790 cites W2086698948 @default.
• W3098566790 cites W2094763276 @default.
• W3098566790 cites W2116885047 @default.
• W3098566790 cites W2140722179 @default.
• W3098566790 cites W2143976934 @default.
• W3098566790 cites W2163889167 @default.
• W3098566790 cites W2228780390 @default.
• W3098566790 cites W2324487866 @default.
• W3098566790 cites W2583721968 @default.
• W3098566790 cites W2736939674 @default.
• W3098566790 cites W2743571816 @default.
• W3098566790 cites W2765253110 @default.
• W3098566790 cites W2786712411 @default.
• W3098566790 cites W2809833540 @default.
• W3098566790 cites W2891723532 @default.
• W3098566790 cites W2919108709 @default.
• W3098566790 cites W3018967490 @default.
• W3098566790 cites W3023083660 @default.
• W3098566790 cites W3039087845 @default.
• W3098566790 doi "https://doi.org/10.1016/j.omtm.2020.11.003" @default.
• W3098566790 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7773564" @default.
• W3098566790 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33426145" @default.
• W3098566790 hasPublicationYear "2021" @default.
• W3098566790 type Work @default.
• W3098566790 sameAs 3098566790 @default.
• W3098566790 citedByCount "8" @default.
• W3098566790 countsByYear W30985667902021 @default.
• W3098566790 countsByYear W30985667902022 @default.
• W3098566790 countsByYear W30985667902023 @default.
• W3098566790 crossrefType "journal-article" @default.
• W3098566790 hasAuthorship W3098566790A5032570492 @default.
• W3098566790 hasAuthorship W3098566790A5038008307 @default.
• W3098566790 hasAuthorship W3098566790A5060434465 @default.
• W3098566790 hasAuthorship W3098566790A5064919780 @default.
• W3098566790 hasAuthorship W3098566790A5069152029 @default.
• W3098566790 hasAuthorship W3098566790A5074650312 @default.
• W3098566790 hasAuthorship W3098566790A5078964807 @default.
• W3098566790 hasAuthorship W3098566790A5082934985 @default.
• W3098566790 hasBestOaLocation W30985667901 @default.
• W3098566790 hasConcept C104317684 @default.
• W3098566790 hasConcept C111599444 @default.
• W3098566790 hasConcept C126322002 @default.
• W3098566790 hasConcept C142724271 @default.
• W3098566790 hasConcept C15152581 @default.
• W3098566790 hasConcept C198826908 @default.
• W3098566790 hasConcept C2778107364 @default.
• W3098566790 hasConcept C2778943923 @default.
• W3098566790 hasConcept C2779030066 @default.
• W3098566790 hasConcept C2780394045 @default.
• W3098566790 hasConcept C40767141 @default.
• W3098566790 hasConcept C54355233 @default.
• W3098566790 hasConcept C55493867 @default.
• W3098566790 hasConcept C71924100 @default.
• W3098566790 hasConcept C86803240 @default.
• W3098566790 hasConcept C92087593 @default.
• W3098566790 hasConceptScore W3098566790C104317684 @default.
• W3098566790 hasConceptScore W3098566790C111599444 @default.
• W3098566790 hasConceptScore W3098566790C126322002 @default.
• W3098566790 hasConceptScore W3098566790C142724271 @default.
• W3098566790 hasConceptScore W3098566790C15152581 @default.
• W3098566790 hasConceptScore W3098566790C198826908 @default.
• W3098566790 hasConceptScore W3098566790C2778107364 @default.
• W3098566790 hasConceptScore W3098566790C2778943923 @default.
• W3098566790 hasConceptScore W3098566790C2779030066 @default.
• W3098566790 hasConceptScore W3098566790C2780394045 @default.
• W3098566790 hasConceptScore W3098566790C40767141 @default.
• W3098566790 hasConceptScore W3098566790C54355233 @default.
• W3098566790 hasConceptScore W3098566790C55493867 @default.
• W3098566790 hasConceptScore W3098566790C71924100 @default.
• W3098566790 hasConceptScore W3098566790C86803240 @default.
• W3098566790 hasConceptScore W3098566790C92087593 @default.
• W3098566790 hasFunder F4320311405 @default.
• W3098566790 hasLocation W30985667901 @default.

• next